The present application relates generally to the treatment of integumentary wounds (including chronic and acute wounds involving both cutaneous and mucous membranes), and in particular to topical formulations and instillates comprising one or more cannabinoids, terpenes, and flavonoids, kits, and methods for treating integumentary wounds, and uses thereof.